首页 > 最新文献

JEADV clinical practice最新文献

英文 中文
Facial Annular Lesions in a 28-Year-Old Man 28岁男性面部环形病变
IF 0.5 Pub Date : 2025-06-27 DOI: 10.1002/jvc2.70104
Maximiliano Maass, Angelo Gonzalez, Paula Giacaman, Ester Santander
<p>A 28-year-old Dominican male, with no significant medical history, presented a 60-day history of asymptomatic facial lesions. These lesions, characterized by annular configurations, progressively increased in size and number. The patient denied any genital or lesions elsewhere on the body. Physical examination revealed multiple skin-colored papules, 3–5 mm in diameter, located on the midline of the forehead, bilateral cheeks, and anterior cervical region. Most of these papules were coalescent, forming various annular, spiral, or linear structures, all with a hyperpigmented base (Figures 1 and 2). Dermatoscopy showed no specific findings. No other lesions were observed on the rest of the body or mucous membranes. When questioned specifically, the patient denied previous infectious episodes, recent use of new medications or vaccines, or family members with similar symptoms. A blood test was performed to assess possible causes of facial annular lesions. At the same time, it was decided to perform empirical treatment as a diagnostic test.</p><p>Syphilis is a chronic sexually transmitted infection, caused by <i>Treponema pallidum</i>, characterized by a diverse range of clinical manifestations, potentially involving multiple organs [<span>1</span>]. This disease progresses through stages of infectious activity, including primary, secondary, and tertiary syphilis, alternating with periods of latency [<span>2</span>]. Secondary syphilis represents the expression of hematogenous dissemination of the microorganism, with mucocutaneous lesions being the most common manifestation, typically presenting as a diffuse maculopapular exanthem on the trunk and extremities, frequently associated with palmoplantar involvement [<span>3</span>]. However, a broad spectrum of atypical cutaneous lesions can manifest in this infection, leading to its characterization as “the great imitator,” with presentations including nodular, annular, pustular, pyodermatous, photodistributed papulosquamous lesions, among others [<span>4</span>].</p><p>Annular secondary syphilis, as observed in our patient (Figures 1 and 2), is infrequent, with a prevalence between 5.7% and 13.6%, occurring mostly in children and patients with high phototypes [<span>5, 6</span>]. Within annular lesions, there are different variations that pose a greater diagnostic challenge, even being observed in congenital syphilis [<span>6</span>]. The reason for the great polymorphism of cutaneous lesions as a clinical expression of this infection is still unclear; however, it is thought that pro-inflammatory factors in the dermis, as well as in deeper vascular structures, are involved, generating processes of cutaneous ischemia [<span>7</span>].</p><p>These annular lesions are described from round or oval, slightly scaly papules to verrucous exophytic forms, which can be distributed in complete or incomplete rings, forming polycyclic, concentric or even gyrata-like patterns [<span>8, 9</span>]. These patterns can
一名28岁的多米尼加男性,无明显病史,有60天无症状面部病变史。这些病变以环状结构为特征,其大小和数量逐渐增加。病人否认有生殖器或身体其他部位的病变。体格检查发现多发皮肤色丘疹,直径3-5毫米,位于前额中线、双侧脸颊和颈椎前部。这些丘疹多数为聚结状,形成各种环形、螺旋状或线状结构,均有色素沉着的基部(图1和2)。皮肤镜检查未见特异性发现。在身体的其余部分或粘膜上未观察到其他病变。具体询问时,患者否认有感染史,否认最近使用过新药物或疫苗,否认家庭成员有类似症状。进行血液检查以评估面部环形病变的可能原因。同时,决定进行实证治疗作为诊断试验。梅毒是一种慢性性传播感染,由梅毒螺旋体引起,具有多种临床表现,可能累及多个器官。该病的发展经历了感染活动的各个阶段,包括原发性、继发性和三期梅毒,并伴有潜伏期。继发性梅毒表现为微生物的血液传播,皮肤粘膜病变是最常见的表现,典型表现为躯干和四肢的弥漫性黄斑丘疹,常伴有掌跖受累。然而,在这种感染中可以表现出广泛的非典型皮肤病变,导致其被描述为“伟大的模仿者”,表现为结节状、环状、脓疱状、脓皮状、光分布丘疹鳞状病变等。正如我们的患者(图1和2)所观察到的,环状继发性梅毒并不常见,患病率在5.7%至13.6%之间,主要发生在儿童和高光型患者中[5,6]。在环形病变中,存在不同的变异,这给诊断带来了更大的挑战,甚至在先天性梅毒bbb中也有观察到。皮肤病变作为这种感染的临床表现的巨大多态性的原因尚不清楚;然而,人们认为真皮和深层血管结构中的促炎因子参与了皮肤缺血[7]的产生过程。这些环状病变可为圆形或椭圆形、微鳞状丘疹到疣状外生形式,可呈完整或不完整环状分布,形成多环状、同心状甚至环状分布[8,9]。这些类型可影响头皮、口周区、躯干、肛周和生殖器区域,后者被认为是罕见的,然而,观察到的频率越来越高[9,10]。考虑到这些病变的特点,有必要与其他环形病变进行鉴别诊断,如环形肉芽肿、环形扁平苔藓、环形牛皮癣、疥疮或bbb10皮肤癣。该病例的独特之处在于面部病变的数量,这些病变丰富而明确,这两种表型特征在这些患者中都不常见。因此,将继发性梅毒作为面部环形病变鉴别诊断的一部分,进行充分的研究和正确的治疗是很重要的,要考虑到使用抗生素的有效和快速反应。Maximiliano Maass, Paula Giacaman和Ester Santander对案例报告进行了概念化,并为其设计做出了贡献。Maximiliano Maass收集了临床数据,包括患者病史、皮肤病学结果和图片。Maximiliano Maass和Angelo González起草了最初的手稿。Maximiliano Maass和Angelo González审查和修订了内容的准确性,清晰度,并确保其科学完整性。所有作者都审阅并批准了稿件的最终版本,并同意对工作的各个方面负责。本文中的患者已书面同意参与研究,并同意使用其未识别、匿名、汇总的数据和病例详细信息(包括照片)进行发表。伦理批准:不适用。作者声明无利益冲突。支持本研究结果的数据可向通讯作者索取。由于隐私或道德限制,这些数据不会公开。
{"title":"Facial Annular Lesions in a 28-Year-Old Man","authors":"Maximiliano Maass,&nbsp;Angelo Gonzalez,&nbsp;Paula Giacaman,&nbsp;Ester Santander","doi":"10.1002/jvc2.70104","DOIUrl":"https://doi.org/10.1002/jvc2.70104","url":null,"abstract":"&lt;p&gt;A 28-year-old Dominican male, with no significant medical history, presented a 60-day history of asymptomatic facial lesions. These lesions, characterized by annular configurations, progressively increased in size and number. The patient denied any genital or lesions elsewhere on the body. Physical examination revealed multiple skin-colored papules, 3–5 mm in diameter, located on the midline of the forehead, bilateral cheeks, and anterior cervical region. Most of these papules were coalescent, forming various annular, spiral, or linear structures, all with a hyperpigmented base (Figures 1 and 2). Dermatoscopy showed no specific findings. No other lesions were observed on the rest of the body or mucous membranes. When questioned specifically, the patient denied previous infectious episodes, recent use of new medications or vaccines, or family members with similar symptoms. A blood test was performed to assess possible causes of facial annular lesions. At the same time, it was decided to perform empirical treatment as a diagnostic test.&lt;/p&gt;&lt;p&gt;Syphilis is a chronic sexually transmitted infection, caused by &lt;i&gt;Treponema pallidum&lt;/i&gt;, characterized by a diverse range of clinical manifestations, potentially involving multiple organs [&lt;span&gt;1&lt;/span&gt;]. This disease progresses through stages of infectious activity, including primary, secondary, and tertiary syphilis, alternating with periods of latency [&lt;span&gt;2&lt;/span&gt;]. Secondary syphilis represents the expression of hematogenous dissemination of the microorganism, with mucocutaneous lesions being the most common manifestation, typically presenting as a diffuse maculopapular exanthem on the trunk and extremities, frequently associated with palmoplantar involvement [&lt;span&gt;3&lt;/span&gt;]. However, a broad spectrum of atypical cutaneous lesions can manifest in this infection, leading to its characterization as “the great imitator,” with presentations including nodular, annular, pustular, pyodermatous, photodistributed papulosquamous lesions, among others [&lt;span&gt;4&lt;/span&gt;].&lt;/p&gt;&lt;p&gt;Annular secondary syphilis, as observed in our patient (Figures 1 and 2), is infrequent, with a prevalence between 5.7% and 13.6%, occurring mostly in children and patients with high phototypes [&lt;span&gt;5, 6&lt;/span&gt;]. Within annular lesions, there are different variations that pose a greater diagnostic challenge, even being observed in congenital syphilis [&lt;span&gt;6&lt;/span&gt;]. The reason for the great polymorphism of cutaneous lesions as a clinical expression of this infection is still unclear; however, it is thought that pro-inflammatory factors in the dermis, as well as in deeper vascular structures, are involved, generating processes of cutaneous ischemia [&lt;span&gt;7&lt;/span&gt;].&lt;/p&gt;&lt;p&gt;These annular lesions are described from round or oval, slightly scaly papules to verrucous exophytic forms, which can be distributed in complete or incomplete rings, forming polycyclic, concentric or even gyrata-like patterns [&lt;span&gt;8, 9&lt;/span&gt;]. These patterns can","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"4 5","pages":"1278-1280"},"PeriodicalIF":0.5,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.70104","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145625979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atypical Gamma-Delta-Positive T-Cell Lymphoproliferation With Clinical Features of Lymphomatoid Papulosis in Three Children 3例儿童非典型γ - δ阳性t细胞增生伴淋巴样丘疹病的临床特征
IF 0.5 Pub Date : 2025-06-26 DOI: 10.1002/jvc2.70085
Lachance Madeleine, Ram-Wolff Caroline, Delisle Bernard, Sigg Nina, Bataille Pauline, Bourrat Emmanuelle, Dumont Maëlle, Battesti Gilles, Bozonnat Alizée, Louveau Baptiste, Mourah Samia, Moins-Teisserenc Hélène, Bagot Martine, Lamant Laurence, Croue Anne, Michalak Sophie, BAH Ismael, Kempf Werner, Battistella Maxime, De Masson Adèle

Primary cutaneous gamma-delta T-cell lymphoma has been described as an aggressive entity with a poor prognosis. However, gamma-delta T-cell receptor expression has been described in various types of skin lymphoproliferations. Paediatric cases of LyP are increasingly recognized, but paediatric LyP with a gamma-delta phenotype have been rarely described. We report three paediatric patients with indolent gamma-delta lymphoproliferation, with a relapsing-remitting course evoking LyP. These three cases emphasize that TCR gamma-delta expression in a lymphoproliferation is not a synonym of gamma-delta lymphoma. Indeed, these cases raise the question of a paediatric variant of CD30-negative lymphomatoid papulosis with histological features of atypical gamma-delta-positive T-cell lymphoproliferation and underline the necessity of cautious clinico-histological correlation when facing a gamma-delta lymphoproliferation to avoid overtreatment.

原发性皮肤γ - δ t细胞淋巴瘤被描述为一种预后不良的侵袭性实体。然而,γ - δ t细胞受体的表达已在各种类型的皮肤淋巴细胞增生中被描述。小儿LyP病例越来越多的认识,但小儿LyP与γ - δ表型很少被描述。我们报告了三名患有惰性γ - δ淋巴细胞增生的儿科患者,其复发缓解过程引起LyP。这三个病例强调TCR在淋巴增生中表达γ - δ并不是γ - δ淋巴瘤的同义词。事实上,这些病例提出了cd30阴性淋巴样丘疹病的儿科变体的问题,其组织学特征是非典型γ - δ阳性t细胞淋巴细胞增殖,并强调了在面对γ - δ淋巴细胞增殖时谨慎的临床组织学相关性,以避免过度治疗的必要性。
{"title":"Atypical Gamma-Delta-Positive T-Cell Lymphoproliferation With Clinical Features of Lymphomatoid Papulosis in Three Children","authors":"Lachance Madeleine,&nbsp;Ram-Wolff Caroline,&nbsp;Delisle Bernard,&nbsp;Sigg Nina,&nbsp;Bataille Pauline,&nbsp;Bourrat Emmanuelle,&nbsp;Dumont Maëlle,&nbsp;Battesti Gilles,&nbsp;Bozonnat Alizée,&nbsp;Louveau Baptiste,&nbsp;Mourah Samia,&nbsp;Moins-Teisserenc Hélène,&nbsp;Bagot Martine,&nbsp;Lamant Laurence,&nbsp;Croue Anne,&nbsp;Michalak Sophie,&nbsp;BAH Ismael,&nbsp;Kempf Werner,&nbsp;Battistella Maxime,&nbsp;De Masson Adèle","doi":"10.1002/jvc2.70085","DOIUrl":"https://doi.org/10.1002/jvc2.70085","url":null,"abstract":"<p>Primary cutaneous gamma-delta T-cell lymphoma has been described as an aggressive entity with a poor prognosis. However, gamma-delta T-cell receptor expression has been described in various types of skin lymphoproliferations. Paediatric cases of LyP are increasingly recognized, but paediatric LyP with a gamma-delta phenotype have been rarely described. We report three paediatric patients with indolent gamma-delta lymphoproliferation, with a relapsing-remitting course evoking LyP. These three cases emphasize that TCR gamma-delta expression in a lymphoproliferation is not a synonym of gamma-delta lymphoma. Indeed, these cases raise the question of a paediatric variant of CD30-negative lymphomatoid papulosis with histological features of atypical gamma-delta-positive T-cell lymphoproliferation and underline the necessity of cautious clinico-histological correlation when facing a gamma-delta lymphoproliferation to avoid overtreatment.</p>","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"4 4","pages":"883-886"},"PeriodicalIF":0.5,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.70085","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144923561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Longstanding Perianal Ulcers 长期肛周溃疡
IF 0.5 Pub Date : 2025-06-24 DOI: 10.1002/jvc2.70098
Narachai Julanon, Thanaphon Anutraungkool, Sirawich Jessadapattarakul, Vincent Piguet
<p>A 35-year-old Thai man presented with a perianal ulcerative lesion persisting for 10 years, refractory to antibiotics. He has experienced recurrent abscesses on the scalp, axillae, and perianal region since the age of 25, which progressed to multiple sinus tracts and extensive scarring in the perianal area—clinical features consistent with hidradenitis suppurativa (HS), Hurley stage III. However, he has not been adherent to treatment. He reported no history of fever, weight loss, chronic diarrhoea, abdominal pain, dysuria, or abnormal urine coloration. Examination revealed an erythematous plaque with an ulcer on a scarred HS background (Figure 1). No active HS lesions were present elsewhere. A pus swab for microbiological analysis (Figure 2) and a skin biopsy (Figure 3) from the perianal ulcer were performed.</p><p>Tuberculosis affects over 10 million individuals globally each year, with the highest incidence reported in Southeast Asia, China, India, and Africa [<span>1</span>]. Tuberculosis can manifest as skin lesions, classified into cutaneous tuberculosis (direct skin infection) and tuberculid (a skin reaction to tuberculosis).</p><p>Cutaneous tuberculosis, a rare form constituting 1%–2% of extrapulmonary tuberculosis cases [<span>1</span>], has diverse clinical manifestations influenced by bacillary load, which reflects the host's cell-mediated immune response, and transmission route (either endogenous or exogenous).</p><p>Periorificial tuberculosis arises from <i>Mycobacterium tuberculosis</i> spread from luminal structures to body orifices. Perianal tuberculosis may represent its manifestation in the perianal area resulting from gastrointestinal tract tuberculosis. In our case, colonoscopy was not performed to investigate further as the patient exhibited no gastrointestinal symptoms, despite the presence of chronic perianal ulcers, thereby reducing the likelihood of gastrointestinal tuberculosis.</p><p>Pulmonary and perianal tuberculosis can coexist in approximately half of the patients [<span>2</span>]. Potential mechanisms include perianal contamination following the ingestion of sputum containing high bacilli or hematogenous spreading [<span>2</span>]. This rationale prompted the use of chest radiography and sputum testing in our case, both of which revealed no evidence of pulmonary tuberculosis. In the absence of evidence for pulmonary or gastrointestinal tuberculosis in our case, an alternative possibility is that the bacilli were acquired through an exogenous environmental route. Chronic inflammation from HS may induce local immunosuppression, increasing susceptibility to mycobacterial infection [<span>3, 4</span>]. Direct inoculation of environmental bacilli through perianal skin is also plausible, as pathogen remains viable in the environment for extended periods [<span>5</span>]. This presentation may be more consistent with primary inoculation tuberculosis, or tuberculous chancre, based on the ulcerative morphology, rather tha
一个35岁的泰国男人提出了一个持续10年的肛周溃疡性病变,抗生素难治性。患者自25岁起头皮、腋窝和肛周区域反复出现脓肿,并发展为多个窦道和肛周区域广泛瘢痕形成,临床特征符合化脓性汗腺炎(HS), Hurley III期。然而,他并没有坚持治疗。患者无发热、体重减轻、慢性腹泻、腹痛、排尿困难或异常尿色史。检查显示HS背景上有一个带溃疡的红斑斑块(图1)。其他部位未见活动性HS病变。对肛周溃疡进行脓液拭子微生物学分析(图2)和皮肤活检(图3)。结核病每年影响全球1000多万人,据报道,东南亚、中国、印度和非洲的发病率最高。结核病可表现为皮肤病变,分为皮肤结核(直接皮肤感染)和结核菌(对结核病的皮肤反应)。皮肤结核是一种罕见的形式,占肺外结核病例的1%-2%,其临床表现受细菌负荷的影响,反映了宿主细胞介导的免疫反应和传播途径(内源性或外源性)。口周结核是由结核分枝杆菌从管腔结构扩散到体腔引起的。肛周结核可能表现在胃肠道结核引起的肛周区域。在我们的病例中,尽管存在慢性肛周溃疡,但由于患者没有胃肠道症状,因此没有进行结肠镜检查以进一步调查,从而降低了胃肠道结核的可能性。大约一半的患者可同时患有肺结核和肛周结核。潜在的机制包括摄入含有高杆菌的痰液或血行性播散[2]后的肛周污染。这一理论基础促使我们在本病例中使用胸片和痰液检查,两者均未发现肺结核的证据。在本病例中没有肺结核或胃肠道结核的证据,另一种可能性是杆菌是通过外源性环境途径获得的。HS引起的慢性炎症可引起局部免疫抑制,增加对分枝杆菌感染的易感性[3,4]。通过肛周皮肤直接接种环境杆菌也是可行的,因为病原体在环境中可以存活较长时间。根据溃疡形态,这种表现可能更符合初次接种结核或结核性下疳,而不是典型表现为疣状斑块的疣状皮肤结核。虽然结核病经常发生在免疫功能低下的个体,但只有18.6%的肛周结核病例发生在免疫功能低下的宿主[6]。肛周结核可表现为红棕色软结节,合并成大浸润性斑块伴溃疡、肛周脓肿、肛瘘、肛裂或肿块样疣状病变,以溃疡形式最为常见[2,6]。肛周结核可模拟梅毒、克罗恩病、鳞状细胞癌、乳腺外佩吉特病、坏疽性脓皮病和HS等疾病。由于其慢性、缓慢的病程和多样的临床表现,诊断常常延迟,正如我们的病例所见,从症状到诊断的平均持续时间为34.6个月。HS是一种影响大汗腺的慢性炎症性皮肤病,在许多欧洲国家流行于超过1%的人口中。HS通常表现在三节间和肛门生殖器区域,特征是炎症结节、脓肿、窦道和疤痕,其中结节和脓肿可破裂,形成长期病变的溃疡。由于有共同的形态学特征[8],肛周结核被误诊为HS已有文献记载。这两种情况的共同发生也有报道。在本病例中,一些临床线索提示肛周HS的可能性较低。首先,HS在亚洲人群中不太常见,而结核病则更为普遍。其次,孤立性肛周HS是罕见的,没有额外的三叉间受累。最后,我们的病例表现为慢性进行性病程,而不是HS的典型复发模式。虽然HS通常在临床上诊断,但在非典型肛周表现中,建议进行全面调查,排除其他疾病,特别是结核病。肛周结核的诊断主要依赖于结核分枝杆菌的识别。在一项对37份不同皮肤结核类型的皮肤活检样本的研究中,PCR的阳性率最高(79。 4%),其次是组织病理学(73.5%),Löwenstein-Jensen培养基培养(29.4%)和涂片检查(5.8%)[10]。采用多种诊断方式可提高灵敏度。肛周结核采用标准结核治疗,通常在数周内溃疡消退。所有作者都对研究的构思和设计做出了贡献。材料准备、数据收集和手稿起草工作由n.j.、t.a.、S.J.和V.P.负责,他们对手稿中重要的知识内容进行了严格的审查。所有作者都阅读并批准了最终稿件。本研究已获得孔敬大学人类研究伦理委员会(HE671625)的批准。本文中的患者已书面同意参与研究,并同意使用其未识别、匿名、汇总的数据和病例详细信息(包括照片)发表。Vincent Piguet获得了AbbVie、Bausch Health、Boehringer Ingelheim、Bristol Myers Squibb、Celgene、Eli Lilly、Incyte、Janssen、LEO Pharma、L’oracimal、Novartis、Organon、Pfizer、Sandoz和Sanofi的资助;从赛诺菲获得演讲报酬或酬金;参与LEO Pharma、Novartis、Sanofi、Union Therapeutics、Abbvie和UCB的顾问委员会;并接受了欧莱雅公司的设备捐赠。其余作者声明无利益冲突。支持本研究结果的数据可向通讯作者索取。由于隐私或道德限制,这些数据不会公开。
{"title":"Longstanding Perianal Ulcers","authors":"Narachai Julanon,&nbsp;Thanaphon Anutraungkool,&nbsp;Sirawich Jessadapattarakul,&nbsp;Vincent Piguet","doi":"10.1002/jvc2.70098","DOIUrl":"https://doi.org/10.1002/jvc2.70098","url":null,"abstract":"&lt;p&gt;A 35-year-old Thai man presented with a perianal ulcerative lesion persisting for 10 years, refractory to antibiotics. He has experienced recurrent abscesses on the scalp, axillae, and perianal region since the age of 25, which progressed to multiple sinus tracts and extensive scarring in the perianal area—clinical features consistent with hidradenitis suppurativa (HS), Hurley stage III. However, he has not been adherent to treatment. He reported no history of fever, weight loss, chronic diarrhoea, abdominal pain, dysuria, or abnormal urine coloration. Examination revealed an erythematous plaque with an ulcer on a scarred HS background (Figure 1). No active HS lesions were present elsewhere. A pus swab for microbiological analysis (Figure 2) and a skin biopsy (Figure 3) from the perianal ulcer were performed.&lt;/p&gt;&lt;p&gt;Tuberculosis affects over 10 million individuals globally each year, with the highest incidence reported in Southeast Asia, China, India, and Africa [&lt;span&gt;1&lt;/span&gt;]. Tuberculosis can manifest as skin lesions, classified into cutaneous tuberculosis (direct skin infection) and tuberculid (a skin reaction to tuberculosis).&lt;/p&gt;&lt;p&gt;Cutaneous tuberculosis, a rare form constituting 1%–2% of extrapulmonary tuberculosis cases [&lt;span&gt;1&lt;/span&gt;], has diverse clinical manifestations influenced by bacillary load, which reflects the host's cell-mediated immune response, and transmission route (either endogenous or exogenous).&lt;/p&gt;&lt;p&gt;Periorificial tuberculosis arises from &lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt; spread from luminal structures to body orifices. Perianal tuberculosis may represent its manifestation in the perianal area resulting from gastrointestinal tract tuberculosis. In our case, colonoscopy was not performed to investigate further as the patient exhibited no gastrointestinal symptoms, despite the presence of chronic perianal ulcers, thereby reducing the likelihood of gastrointestinal tuberculosis.&lt;/p&gt;&lt;p&gt;Pulmonary and perianal tuberculosis can coexist in approximately half of the patients [&lt;span&gt;2&lt;/span&gt;]. Potential mechanisms include perianal contamination following the ingestion of sputum containing high bacilli or hematogenous spreading [&lt;span&gt;2&lt;/span&gt;]. This rationale prompted the use of chest radiography and sputum testing in our case, both of which revealed no evidence of pulmonary tuberculosis. In the absence of evidence for pulmonary or gastrointestinal tuberculosis in our case, an alternative possibility is that the bacilli were acquired through an exogenous environmental route. Chronic inflammation from HS may induce local immunosuppression, increasing susceptibility to mycobacterial infection [&lt;span&gt;3, 4&lt;/span&gt;]. Direct inoculation of environmental bacilli through perianal skin is also plausible, as pathogen remains viable in the environment for extended periods [&lt;span&gt;5&lt;/span&gt;]. This presentation may be more consistent with primary inoculation tuberculosis, or tuberculous chancre, based on the ulcerative morphology, rather tha","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"4 5","pages":"1274-1277"},"PeriodicalIF":0.5,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.70098","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145625964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Superficial Pustular Folliculitis of the Face and Neck—A Non-Infectious Eruption Responding to Topical Steroids 面部和颈部的浅表性脓疱性毛囊炎-对局部类固醇反应的非感染性爆发
IF 0.5 Pub Date : 2025-06-23 DOI: 10.1002/jvc2.70102
Hui-Peng Huang, Chang-Ming Huang, Chao-Kai Hsu, Chao-Chun Yang, Julia Yu-Yun Lee

Background

We have seen patients presenting with tiny, superficial follicular pustules on the face and neck that appeared distinct from common or well-known facial pustular dermatoses, such as acne vulgaris, rosacea, demodicosis, and Ofuji's disease.

Objectives

We aimed to describe the clinicopathologic features, differential diagnosis, and treatment of this pustular eruption in southern Taiwan.

Methods

We retrospectively reviewed the medical records and clinical photos of cases presenting with tiny, superficial follicular pustules on the face and/or neck during July 2017–March 2022. Cases of rosacea, acne vulgaris, demodicosis, and Ofuji's disease were excluded.

Results

A total of 27 patients (26 females and 1 male; mean age of 25.2 ± 4.3 years) were included for analysis. All patients presented with monomorphous, discrete, tiny, superficial pustules on the face and/or neck. The pustules varied from a few to hundreds in number. The eruptions were distributed on the face in 12 (44.4%) patients, the face and neck in 14 (51.8%), and the neck in one (3.7%), and was itchy in 44.4%. The pustules lasted 1 day to 1 month, mostly within 1 week, before treatment, and was recurrent in 81% of cases with 2–20 episodes individually. Twenty-four of the 25 (96%) patients responded well to steroids with complete clearance of pustules. Skin biopsy of pustules performed in three cases showed infundibular pustules filled with neutrophils and a perivascular lymphohistiocytic infiltrate in the dermis. Gram staining revealed negative finding. Bacterial cultures performed in two patients revealed Cutibacterium acnes.

Conclusions

Based on our observation, we would like to propose the term ‘superficial pustular folliculitis of the face and neck’ (SPFFN) for this type of eruption. It is important to be familiar with this particular type of follicular pustulosis, especially when dealing with young females as the pustules respond well to low-potency topical steroids.

背景:我们曾见过面部和颈部出现微小的浅表滤泡性脓疱的患者,其表现与常见或众所周知的面部脓疱性皮肤病(如寻常痤疮、酒渣鼻、demodemosis和Ofuji病)不同。目的探讨台湾南部一种脓疱的临床病理特征、鉴别诊断及治疗方法。方法回顾性分析2017年7月至2022年3月期间面部和/或颈部出现微小浅表性滤泡性脓疱的病例的医疗记录和临床照片。排除酒渣鼻、寻常性痤疮、蠕虫病和大富士病。结果共纳入27例患者,其中女性26例,男性1例,平均年龄25.2±4.3岁。所有患者均表现为面部和/或颈部单形、离散、微小、浅表脓疱。脓疱的数量从几个到几百个不等。皮疹分布于面部12例(44.4%),面部及颈部14例(51.8%),颈部1例(3.7%),瘙痒性皮疹占44.4%。治疗前脓疱持续1天~ 1个月,多在1周内出现,81%复发,单次2 ~ 20次。25例患者中有24例(96%)对类固醇反应良好,脓疱完全清除。三例脓疱的皮肤活检显示脓疱充满中性粒细胞和真皮血管周围淋巴组织细胞浸润。革兰氏染色呈阴性。两名患者的细菌培养结果显示为痤疮表皮杆菌。根据我们的观察,我们建议将这种类型的爆发称为“面部和颈部浅表性脓疱性毛囊炎”(SPFFN)。重要的是要熟悉这种特殊类型的滤泡性脓疱病,特别是在处理年轻女性时,因为脓疱对低效力的局部类固醇反应良好。
{"title":"Superficial Pustular Folliculitis of the Face and Neck—A Non-Infectious Eruption Responding to Topical Steroids","authors":"Hui-Peng Huang,&nbsp;Chang-Ming Huang,&nbsp;Chao-Kai Hsu,&nbsp;Chao-Chun Yang,&nbsp;Julia Yu-Yun Lee","doi":"10.1002/jvc2.70102","DOIUrl":"https://doi.org/10.1002/jvc2.70102","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>We have seen patients presenting with tiny, superficial follicular pustules on the face and neck that appeared distinct from common or well-known facial pustular dermatoses, such as acne vulgaris, rosacea, demodicosis, and Ofuji's disease.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>We aimed to describe the clinicopathologic features, differential diagnosis, and treatment of this pustular eruption in southern Taiwan.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We retrospectively reviewed the medical records and clinical photos of cases presenting with tiny, superficial follicular pustules on the face and/or neck during July 2017–March 2022. Cases of rosacea, acne vulgaris, demodicosis, and Ofuji's disease were excluded.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 27 patients (26 females and 1 male; mean age of 25.2 ± 4.3 years) were included for analysis. All patients presented with monomorphous, discrete, tiny, superficial pustules on the face and/or neck. The pustules varied from a few to hundreds in number. The eruptions were distributed on the face in 12 (44.4%) patients, the face and neck in 14 (51.8%), and the neck in one (3.7%), and was itchy in 44.4%. The pustules lasted 1 day to 1 month, mostly within 1 week, before treatment, and was recurrent in 81% of cases with 2–20 episodes individually. Twenty-four of the 25 (96%) patients responded well to steroids with complete clearance of pustules. Skin biopsy of pustules performed in three cases showed infundibular pustules filled with neutrophils and a perivascular lymphohistiocytic infiltrate in the dermis. Gram staining revealed negative finding. Bacterial cultures performed in two patients revealed <i>Cutibacterium acnes</i>.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Based on our observation, we would like to propose the term ‘superficial pustular folliculitis of the face and neck’ (SPFFN) for this type of eruption. It is important to be familiar with this particular type of follicular pustulosis, especially when dealing with young females as the pustules respond well to low-potency topical steroids.</p>\u0000 </section>\u0000 </div>","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"4 5","pages":"1057-1067"},"PeriodicalIF":0.5,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.70102","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145625890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bilateral Nicolau Syndrome Following Intramuscular Gentamicin Injections 肌肉注射庆大霉素后的双侧Nicolau综合征
IF 0.5 Pub Date : 2025-06-22 DOI: 10.1002/jvc2.70088
Konstantina Kotsia, Louise Gueissaz, Roland Blum, Luca Borradori

A 38-year-old female presented with a 4-week history of painful livedoid violaceous plaques with retiform purpura and central necrosis on both anterior thighs (Figure 1A,B). The lesions acutely developed following intramuscular gentamicin injections into the vastus lateralis muscles. Light microscopy studies of a skin biopsy demonstrated intravascular thrombi and necrosis in the dermis and in the subcutis. NMR imaging studies confirmed subcutaneous tissue involvement. Nicolau syndrome (NS) was diagnosed. Initial management included intravenous heparin, oral prednisolone (1 mg/kg/day), analgesics, and topical antiseptic wound care. However, after 2 weeks of minimal improvement, surgical debridement was performed. The resultant defects were reconstructed using a biodegradable polyurethane dermal matrix (NovoSorb BTM). Complete wound healing was achieved by using a human placental allograft (NuShield) 3 months later.

NS, also called embolia cutis medicamentosa, is a rare severe iatrogenic complication following usually intramuscular injection of various drugs, including most frequently nonsteroidal anti-inflammatory agents and antibiotics [1]. Our case with bilateral involvement was striking. To reduce the occurrence risk of NS, healthcare workers should be both restrictive in prescribing injections and familiar with the correct injection techniques including proper needle length, injection sites and the Z-track method [2, 3]. Potential risk factors, including adiposity, female gender and diabetes, should be considered [2, 4].

K.K., L.G. and R.B. drafted the manuscript, while L.B. critically revised it. All authors reviewed and approved the final manuscript and gave consent for publication.

The patient in this manuscript has given written informed consent for the use of their deidentified, anonymized, aggregated data and their case details (including photographs) for publication. Ethical Approval: not applicable.

The authors declare no conflicts of interest.

Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.

一名38岁女性,在大腿前两侧有疼痛的活样紫色斑块伴网状紫癜和中央坏死4周的病史(图1A,B)。肌内庆大霉素注射入股外侧肌后,病变急性发展。皮肤活检的光镜检查显示真皮和皮下有血管内血栓和坏死。核磁共振成像研究证实皮下组织受累。诊断为Nicolau综合征(NS)。最初的治疗包括静脉注射肝素,口服强的松龙(1mg /kg/天),镇痛药和局部消毒伤口护理。然而,在2周的轻微改善后,进行了手术清创。使用可生物降解的聚氨酯真皮基质(NovoSorb BTM)重建所产生的缺陷。3个月后使用人类胎盘异体移植(nusshield)实现伤口完全愈合。NS,也称为药物性皮肤栓塞,是一种罕见的严重医源性并发症,通常由肌肉注射各种药物引起,包括最常见的非甾体抗炎药和抗生素。我们双方参与的案例很引人注目。为了降低NS的发生风险,医护人员应严格控制注射处方,并熟悉正确的注射技术,包括适当的针长、注射部位和z径法[2,3]。应考虑潜在的危险因素,包括肥胖、女性和糖尿病[2,4]。L.G.和R.B.起草了手稿,而L.B.则对其进行了严格的修改。所有作者审阅并批准了最终稿件,并同意发表。本文中的患者已书面知情同意使用其去身份化、匿名化、汇总的数据及其病例细节(包括照片)进行出版。伦理批准:不适用。作者声明无利益冲突。数据共享不适用于本文,因为在当前研究期间没有生成或分析数据集。
{"title":"Bilateral Nicolau Syndrome Following Intramuscular Gentamicin Injections","authors":"Konstantina Kotsia,&nbsp;Louise Gueissaz,&nbsp;Roland Blum,&nbsp;Luca Borradori","doi":"10.1002/jvc2.70088","DOIUrl":"https://doi.org/10.1002/jvc2.70088","url":null,"abstract":"<p>A 38-year-old female presented with a 4-week history of painful livedoid violaceous plaques with retiform purpura and central necrosis on both anterior thighs (Figure 1A,B). The lesions acutely developed following intramuscular gentamicin injections into the vastus lateralis muscles. Light microscopy studies of a skin biopsy demonstrated intravascular thrombi and necrosis in the dermis and in the subcutis. NMR imaging studies confirmed subcutaneous tissue involvement. Nicolau syndrome (NS) was diagnosed. Initial management included intravenous heparin, oral prednisolone (1 mg/kg/day), analgesics, and topical antiseptic wound care. However, after 2 weeks of minimal improvement, surgical debridement was performed. The resultant defects were reconstructed using a biodegradable polyurethane dermal matrix (NovoSorb BTM). Complete wound healing was achieved by using a human placental allograft (NuShield) 3 months later.</p><p>NS, also called embolia cutis medicamentosa, is a rare severe iatrogenic complication following usually intramuscular injection of various drugs, including most frequently nonsteroidal anti-inflammatory agents and antibiotics [<span>1</span>]. Our case with bilateral involvement was striking. To reduce the occurrence risk of NS, healthcare workers should be both restrictive in prescribing injections and familiar with the correct injection techniques including proper needle length, injection sites and the Z-track method [<span>2, 3</span>]. Potential risk factors, including adiposity, female gender and diabetes, should be considered [<span>2, 4</span>].</p><p>K.K., L.G. and R.B. drafted the manuscript, while L.B. critically revised it. All authors reviewed and approved the final manuscript and gave consent for publication.</p><p>The patient in this manuscript has given written informed consent for the use of their deidentified, anonymized, aggregated data and their case details (including photographs) for publication. Ethical Approval: not applicable.</p><p>The authors declare no conflicts of interest.</p><p>Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.</p>","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"4 5","pages":"1249-1250"},"PeriodicalIF":0.5,"publicationDate":"2025-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.70088","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145625914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Tolerability of Brodalumab in 42 Adult Patients With Moderate to Severe Psoriasis: First French Real-Life Case Series on Hard-to-Treat Areas Brodalumab在42例成人中重度牛皮癣患者中的疗效和耐受性:法国首个难以治疗地区的真实病例系列
IF 0.5 Pub Date : 2025-06-20 DOI: 10.1002/jvc2.70069
Marc Perrussel, Bruno Sassolas

Background

Psoriatic hard-to-treat areas (scalp, palmoplantar, genital and nails) are associated with lower efficacy, treatment discontinuation and impaired quality of life. Recent biotherapies offer a new perspective for their treatment. Among them brodalumab is indicated for the treatment of moderate-to-severe plaque psoriasis in adults requiring systemic therapy. No French data are available on the effectiveness of brodalumab on hard-to-treat areas.

Objectives

To assess the effectiveness and safety of brodalumab in real life on psoriatic hard-to-treat areas.

Methods

Retrospective multicenter study including 42 psoriasis adults which received at least one injection of brodalumab from January 2022 through May 2024 and were followed for a minimum period of 2 months after initiation. Scores were collected at baseline and between 2 and 20 months after treatment initiation: BSA (body surface area), PASI (psoriasis area severity index), PGA-G (Physician's Global Assessment of genitalia), ppPASI (Palmoplantar Psoriasis Area and Severity Index), NAPSI (Nail Psoriasis Severity Index) and PSSI (Psoriasis Scalp Severity Index). DLQI (Dermatology Life Quality Index) was calculated to assess the impact on quality of life. Tolerance and potential adverse events were reported.

Results

The mean BSA at baseline was 16.3%; mean baseline scores: PASI 11.9; PGA-G 2.3; ppPASI 14.9; NAPSI 16.3; PSSI 20.2. 92.9% of patients had DLQI ≥ 10. All patients had hard-to-treat areas: scalp 69.0%; nail 50.0%; genital 50.0%; palmoplantar 35.7%. At the end of the follow-up, the mean scores were, respectively: PASI 0.8; PGA-G 0.3; ppPASI 1.1; NAPSI 2.2; PSSI 1.2. PASI < 1 was achieved by 69.0% of patients. Adverse events were reported in 9.5% of patients.

Conclusions

Brodalumab demonstrated clinical efficacy on hard-to-treat areas in just 3 months of treatment, with a median treatment duration of 4.0 months. This important and rapid clinical efficacy was associated with an improvement in quality of life and good tolerance.

背景银屑病难以治疗的部位(头皮、掌足底、生殖器和指甲)与较低的疗效、治疗中断和生活质量受损有关。最近的生物疗法为他们的治疗提供了新的视角。其中,brodalumab适用于需要全身治疗的成人中至重度斑块性银屑病的治疗。没有关于brodalumab在难以治疗区域的有效性的法国数据。目的评价布罗达鲁单抗治疗银屑病难治部位的临床疗效和安全性。方法回顾性多中心研究,包括42例银屑病成人,于2022年1月至2024年5月接受至少一次brodalumab注射,并在开始后至少随访2个月。在基线和治疗开始后2至20个月之间收集评分:BSA(体表面积)、PASI(牛皮癣区域严重指数)、PGA-G(医生生殖器整体评估)、ppPASI(掌跖牛皮癣面积和严重指数)、NAPSI(指甲牛皮癣严重指数)和PSSI(牛皮癣头皮严重指数)。计算DLQI(皮肤病生活质量指数)来评估对生活质量的影响。报告了耐受性和潜在的不良事件。结果基线时平均BSA为16.3%;平均基线得分:PASI 11.9;PGA-G 2.3;ppPASI 14.9;NAPSI 16.3;PSSI 20.2。92.9%的患者DLQI≥10。所有患者均有难以治疗的部位:头皮69.0%;钉50.0%;生殖器50.0%;palmoplantar 35.7%。随访结束时,平均得分分别为:PASI 0.8;PGA-G 0.3;ppPASI 1.1;NAPSI 2.2;PSSI 1.2。69.0%的患者达到PASI <; 1。9.5%的患者报告了不良事件。结论Brodalumab仅在3个月的治疗中就显示出对难治疗区域的临床疗效,中位治疗时间为4.0个月。这种重要和快速的临床疗效与生活质量的改善和良好的耐受性有关。
{"title":"Efficacy and Tolerability of Brodalumab in 42 Adult Patients With Moderate to Severe Psoriasis: First French Real-Life Case Series on Hard-to-Treat Areas","authors":"Marc Perrussel,&nbsp;Bruno Sassolas","doi":"10.1002/jvc2.70069","DOIUrl":"https://doi.org/10.1002/jvc2.70069","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Psoriatic hard-to-treat areas (scalp, palmoplantar, genital and nails) are associated with lower efficacy, treatment discontinuation and impaired quality of life. Recent biotherapies offer a new perspective for their treatment. Among them brodalumab is indicated for the treatment of moderate-to-severe plaque psoriasis in adults requiring systemic therapy. No French data are available on the effectiveness of brodalumab on hard-to-treat areas.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>To assess the effectiveness and safety of brodalumab in real life on psoriatic hard-to-treat areas.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Retrospective multicenter study including 42 psoriasis adults which received at least one injection of brodalumab from January 2022 through May 2024 and were followed for a minimum period of 2 months after initiation. Scores were collected at baseline and between 2 and 20 months after treatment initiation: BSA (body surface area), PASI (psoriasis area severity index), PGA-G (Physician's Global Assessment of genitalia), ppPASI (Palmoplantar Psoriasis Area and Severity Index), NAPSI (Nail Psoriasis Severity Index) and PSSI (Psoriasis Scalp Severity Index). DLQI (Dermatology Life Quality Index) was calculated to assess the impact on quality of life. Tolerance and potential adverse events were reported.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The mean BSA at baseline was 16.3%; mean baseline scores: PASI 11.9; PGA-G 2.3; ppPASI 14.9; NAPSI 16.3; PSSI 20.2. 92.9% of patients had DLQI ≥ 10. All patients had hard-to-treat areas: scalp 69.0%; nail 50.0%; genital 50.0%; palmoplantar 35.7%. At the end of the follow-up, the mean scores were, respectively: PASI 0.8; PGA-G 0.3; ppPASI 1.1; NAPSI 2.2; PSSI 1.2. PASI &lt; 1 was achieved by 69.0% of patients. Adverse events were reported in 9.5% of patients.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Brodalumab demonstrated clinical efficacy on hard-to-treat areas in just 3 months of treatment, with a median treatment duration of 4.0 months. This important and rapid clinical efficacy was associated with an improvement in quality of life and good tolerance.</p>\u0000 </section>\u0000 </div>","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"4 4","pages":"803-810"},"PeriodicalIF":0.5,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.70069","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144923654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimising Vaccination Status in a Belgian Dermatological Immune-Mediated Inflammatory Disease Population: An Education-Based Pro-Active Patient-Centred Approach 在比利时皮肤病免疫介导的炎症性疾病人群中优化疫苗接种状态:以教育为基础的积极以患者为中心的方法
IF 0.5 Pub Date : 2025-06-19 DOI: 10.1002/jvc2.70057
Femke Lieten, Tine Vanhoutvin, Dorien Hunin, Céline Vanvelk, Liesbeth Gilissen, Petra De Haes, An Van Laethem, Francisca Castelijns, Tom Hillary
<div> <section> <h3> Background</h3> <p>Patients with dermatological immune mediated inflammatory diseases (IMIDs) are increasingly treated with immunosuppressive and -modulating drugs. Some of these drugs increase the risk of acquiring infections and more complications can arise during an infection while treated with these agents. Accurate vaccination can prevent these infections and associated complications.</p> </section> <section> <h3> Objectives</h3> <p>To map the vaccination status of dermatological IMID patients receiving immunosuppressive systemic treatment and evaluate the impact of targeted educational interventions on improving it. We also addressed the awareness on the subject among healthcare providers (HCPs).</p> </section> <section> <h3> Methods</h3> <p>In this monocentric prospective study, we mapped the influenza, pneumococcal, hepatitis B and COVID-19 vaccination status of patients with dermatological IMIDs receiving immunosuppressive treatment (baseline) via the national vaccination register (Vaccinnet). We educated patients and HCPs (general practitioners and pharmacists) on the importance and need of vaccination. Two years later their vaccination status was reassessed (follow-up).</p> </section> <section> <h3> Results</h3> <p>From March 2022 until December 2022, we identified 314 patients treated with immunosuppressive drugs for dermatological IMIDs at UZ Leuven. At baseline, vaccination rates were 56.1% for influenza, 50.2% for pneumococcal disease, and 46.0% for hepatitis B. Older individuals (≥ 40 years old) had significantly higher vaccination rates for influenza (<i>p</i> = 0.002), pneumococcal (<i>p</i> = 0.002), and COVID-19 vaccines (<i>p</i> = 0.004), but lower rates for hepatitis B vaccination (<i>p</i> < 0.001) compared to younger patients. At follow-up, influenza vaccination rates remained stable (57.0%, <i>p</i> = 0.579), while pneumococcal, hepatitis B and COVID-19 vaccination rates significantly increased to 60.6% (<i>p</i> < 0.001), 50.0% (<i>p</i> = 0.002), and 80% (<i>p</i> < 0.001), respectively. Notably, a subset of 55 patients initially registered as vaccinated for influenza at baseline were later categorised as unvaccinated, largely due to missing registrations in Vaccinnet.</p> </section> <section> <h3> Conclusions</h3> <p>Thorough education of patients with dermatological IMIDs and HCPs can result in an additional increase of vaccination rates in times of vaccination fatigue. Meticulous registra
皮肤免疫介导性炎症(IMIDs)患者越来越多地使用免疫抑制和调节药物治疗。其中一些药物增加了感染的风险,并且在使用这些药物治疗感染期间可能出现更多并发症。准确的疫苗接种可以预防这些感染和相关并发症。目的了解接受免疫抑制全身性治疗的皮肤病IMID患者的疫苗接种情况,评价针对性教育干预对改善免疫抑制全身性治疗的影响。我们还讨论了医疗保健提供者(HCPs)对这一主题的认识。方法在这项单中心前瞻性研究中,我们通过国家疫苗接种登记(Vaccinnet)绘制了接受免疫抑制治疗的皮肤病IMIDs患者的流感、肺炎球菌、乙型肝炎和COVID-19疫苗接种情况(基线)。我们教育患者和HCPs(全科医生和药剂师)接种疫苗的重要性和必要性。两年后,重新评估他们的疫苗接种状况(随访)。从2022年3月到2022年12月,我们在鲁汶大学医院(UZ Leuven)鉴定了314例接受免疫抑制药物治疗的皮肤病IMIDs患者。基线时,流感疫苗接种率为56.1%,肺炎球菌疫苗接种率为50.2%,乙肝疫苗接种率为46.0%。老年人(≥40岁)流感(p = 0.002)、肺炎球菌(p = 0.002)和COVID-19疫苗接种率显著高于年轻患者(p = 0.004),但乙肝疫苗接种率低于年轻患者(p < 0.001)。随访时,流感疫苗接种率保持稳定(57.0%,p = 0.579),肺炎球菌、乙型肝炎和COVID-19疫苗接种率分别显著提高至60.6% (p < 0.001)、50.0% (p = 0.002)和80% (p < 0.001)。值得注意的是,最初在基线登记为流感疫苗接种的55名患者后来被归类为未接种疫苗,这主要是由于在Vaccinnet中缺少登记。结论对皮肤病IMIDs和HCPs患者进行深入教育,可使疫苗接种疲劳期接种率进一步提高。卫生保健提供者对接种疫苗进行细致的登记是必要的。
{"title":"Optimising Vaccination Status in a Belgian Dermatological Immune-Mediated Inflammatory Disease Population: An Education-Based Pro-Active Patient-Centred Approach","authors":"Femke Lieten,&nbsp;Tine Vanhoutvin,&nbsp;Dorien Hunin,&nbsp;Céline Vanvelk,&nbsp;Liesbeth Gilissen,&nbsp;Petra De Haes,&nbsp;An Van Laethem,&nbsp;Francisca Castelijns,&nbsp;Tom Hillary","doi":"10.1002/jvc2.70057","DOIUrl":"https://doi.org/10.1002/jvc2.70057","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Background&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Patients with dermatological immune mediated inflammatory diseases (IMIDs) are increasingly treated with immunosuppressive and -modulating drugs. Some of these drugs increase the risk of acquiring infections and more complications can arise during an infection while treated with these agents. Accurate vaccination can prevent these infections and associated complications.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objectives&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;To map the vaccination status of dermatological IMID patients receiving immunosuppressive systemic treatment and evaluate the impact of targeted educational interventions on improving it. We also addressed the awareness on the subject among healthcare providers (HCPs).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;In this monocentric prospective study, we mapped the influenza, pneumococcal, hepatitis B and COVID-19 vaccination status of patients with dermatological IMIDs receiving immunosuppressive treatment (baseline) via the national vaccination register (Vaccinnet). We educated patients and HCPs (general practitioners and pharmacists) on the importance and need of vaccination. Two years later their vaccination status was reassessed (follow-up).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;From March 2022 until December 2022, we identified 314 patients treated with immunosuppressive drugs for dermatological IMIDs at UZ Leuven. At baseline, vaccination rates were 56.1% for influenza, 50.2% for pneumococcal disease, and 46.0% for hepatitis B. Older individuals (≥ 40 years old) had significantly higher vaccination rates for influenza (&lt;i&gt;p&lt;/i&gt; = 0.002), pneumococcal (&lt;i&gt;p&lt;/i&gt; = 0.002), and COVID-19 vaccines (&lt;i&gt;p&lt;/i&gt; = 0.004), but lower rates for hepatitis B vaccination (&lt;i&gt;p&lt;/i&gt; &lt; 0.001) compared to younger patients. At follow-up, influenza vaccination rates remained stable (57.0%, &lt;i&gt;p&lt;/i&gt; = 0.579), while pneumococcal, hepatitis B and COVID-19 vaccination rates significantly increased to 60.6% (&lt;i&gt;p&lt;/i&gt; &lt; 0.001), 50.0% (&lt;i&gt;p&lt;/i&gt; = 0.002), and 80% (&lt;i&gt;p&lt;/i&gt; &lt; 0.001), respectively. Notably, a subset of 55 patients initially registered as vaccinated for influenza at baseline were later categorised as unvaccinated, largely due to missing registrations in Vaccinnet.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Thorough education of patients with dermatological IMIDs and HCPs can result in an additional increase of vaccination rates in times of vaccination fatigue. Meticulous registra","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"4 5","pages":"1033-1038"},"PeriodicalIF":0.5,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.70057","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145625777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Sunlight Sanctuary Sporting Smile Sign—A Newly Recognised Physical Sign Indicating That Pore Size Is Related to Sun Exposure 阳光庇护所运动微笑标志-新发现的表明毛孔大小与阳光照射有关的物理标志
IF 0.5 Pub Date : 2025-06-18 DOI: 10.1002/jvc2.70105
C. A. Hopper, C. M. E. Rowland Payne

The Sunlight Sanctuary Sporting Smile Sign (SSSSS) is the absence of enlarged pores in the nasolabial sulcus contrasting with the presence of enlarged pores in the adjacent skin of the cheek. This is an original observation not previously described Figure 1.

In competitive athletes pursuing sun-facing endurance sports, orbicularis oculi and zygomaticus major narrow the eyes whilst levator labii superioris et alaeque nasi elevates the upper lip. The medial cheek metamorphoses from a flat vertical surface into a three-dimensional anterior projection. The superior part of the projection receives almost perpendicular sunshine, whereas the nasolabial sulcus itself is in shade. The sun spared pores of the sulcus do not become enlarged. This constitutes the Sunlight Sanctuary Sporting Smile Sign Figure 2.

The repeatedly sun-exposed cheek suffers solar dermopenia; the shaded sulcus does not. As the superficial dermal support around the irradiated pilosebaceous orifices atrophies, the pores widen; in the shaded areas of the nasolabial sulcus the dermis is spared such atrophy.

In “Silver Blaze,” the critical clue was that the dog did not bark in the night [1].

Because the dog did not bark in the night, Sherlock Holmes deduced that the intruder was known to the dog, i.e. it was the absence of the bark in the night that was the clue that revealed the identity of the culprit. Similarly, it is the absence of enlarged pores in the nasolabial sulci that is the clue that comprises the Sunlight Sanctuary Sporting Smile Sign.

C. A. Hopper: drafting, literature review, manuscript writing and review. C. M. E. Rowland Payne: conceptualisation, manuscript review and final approval of submitted version.

All patients in this manuscript have given written informed consent for participation in the study and the use of their deidentified, anonymized, aggregated data and their case details (including photographs) for publication. Ethical approval is not applicable for this study.

The authors declare no conflicts of interest.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

阳光庇护所运动微笑标志(SSSSS)是指鼻唇沟没有毛孔粗大,而脸颊邻近皮肤的毛孔粗大。这是一个原始的观察结果,没有在前面的图1中描述。在竞技运动员进行面向阳光的耐力运动时,眼轮匝肌和颧大肌会使眼睛变窄,而上唇和鼻翼提肌会使上唇升高。内侧脸颊从一个平坦的垂直表面变成一个三维的前突。凸起的上部分几乎垂直于阳光照射,而鼻唇沟本身则处于阴暗处。阳光下的毛孔不会变大。这就是阳光庇护所运动微笑标志图2。反复暴露在阳光下的脸颊患有日光性皮肤减退症;阴影沟没有。当被照射的毛囊皮脂腺孔周围的表皮支撑萎缩时,毛孔变宽;在鼻唇沟的阴影区真皮没有这种萎缩。在《银光》中,关键的线索是狗在夜间没有吠叫。由于狗在夜间没有吠叫,福尔摩斯推断狗认识闯入者,也就是说,夜间没有吠叫是揭示罪犯身份的线索。同样,在鼻唇沟中没有扩大的毛孔,这是构成阳光庇护所运动微笑标志的线索。A.霍珀:起草、文献综述、手稿撰写和评论。c.m.e.罗兰佩恩:概念,手稿审查和提交版本的最终批准。本文中的所有患者均已书面同意参与本研究,并同意使用其去识别、匿名、汇总的数据和病例详细信息(包括照片)进行发表。伦理批准不适用于本研究。作者声明无利益冲突。支持本研究结果的数据可根据通讯作者的合理要求提供。
{"title":"The Sunlight Sanctuary Sporting Smile Sign—A Newly Recognised Physical Sign Indicating That Pore Size Is Related to Sun Exposure","authors":"C. A. Hopper,&nbsp;C. M. E. Rowland Payne","doi":"10.1002/jvc2.70105","DOIUrl":"https://doi.org/10.1002/jvc2.70105","url":null,"abstract":"<p>The <b>S</b>unlight <b>S</b>anctuary <b>S</b>porting <b>S</b>mile <b>S</b>ign (SSSSS) is the <i>absence</i> of enlarged pores in the nasolabial sulcus contrasting with the <i>presence</i> of enlarged pores in the adjacent skin of the cheek. This is an original observation not previously described Figure 1.</p><p>In competitive athletes pursuing sun-facing endurance sports, orbicularis oculi and zygomaticus major narrow the eyes whilst levator labii superioris et alaeque nasi elevates the upper lip. The medial cheek metamorphoses from a flat vertical surface into a three-dimensional anterior projection. The superior part of the projection receives almost perpendicular sunshine, whereas the nasolabial sulcus itself is in shade. The sun spared pores of the sulcus do not become enlarged. This constitutes the <b>S</b>unlight <b>S</b>anctuary <b>S</b>porting <b>S</b>mile <b>S</b>ign Figure 2.</p><p>The repeatedly sun-exposed cheek suffers solar dermopenia; the shaded sulcus does not. As the superficial dermal support around the irradiated pilosebaceous orifices atrophies, the pores widen; in the shaded areas of the nasolabial sulcus the dermis is spared such atrophy.</p><p>In <i>“Silver Blaze,”</i> the critical clue was that the dog did <i>not</i> bark in the night [<span>1</span>].</p><p>Because the dog did not bark in the night, Sherlock Holmes deduced that the intruder was known to the dog, i.e. it was the <i>absence</i> of the bark in the night that was the clue that revealed the identity of the culprit. Similarly, it is the <i>absence</i> of enlarged pores in the nasolabial sulci that is the clue that comprises the <b>S</b>unlight <b>S</b>anctuary <b>S</b>porting <b>S</b>mile <b>S</b>ign.</p><p><b>C. A. Hopper:</b> drafting, literature review, manuscript writing and review. <b>C. M. E. Rowland Payne:</b> conceptualisation, manuscript review and final approval of submitted version.</p><p>All patients in this manuscript have given written informed consent for participation in the study and the use of their deidentified, anonymized, aggregated data and their case details (including photographs) for publication. Ethical approval is not applicable for this study.</p><p>The authors declare no conflicts of interest.</p><p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p>","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"4 5","pages":"1254-1255"},"PeriodicalIF":0.5,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.70105","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145625594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multiple Bilateral Erythematous and Suppurative Cutaneous Nodules in a 40-Year-Old Indian Female 一例40岁印度女性双侧多发红斑化脓性皮肤结节
IF 0.5 Pub Date : 2025-06-18 DOI: 10.1002/jvc2.70095
Aditi Anand, Shaivy Malik, Charanjeet Ahluwalia
<p>A 40-year-old female presented with multiple chronic nodular swellings distributed across her body, present for the last 1 year. The swellings were located on both arms, trunk, back, left thigh, and the left great toe and were insidious in onset. The patient appeared emaciated, with a calculated body mass index (BMI) of 16.17 kg/m². The nodules varied in size from 2 to 5 cm in diameter and appeared at different times. They were firm in consistency, tender, and were associated with erythema and occasional excoriation. They were variably ulcerated with evidence of active suppuration and necrosis over the nodules (Figures 1 and 2). She denied any history of cough, evening fever, night sweats, or loss of appetite at the time of presentation. Furthermore, there was no history indicative of associated arthralgia, arthritis, neuritis, preceding streptococcal pharyngitis, or inflammatory bowel disease, hypersensitivity, or urticaria. Moreover, she was not on any chronic medication for any other ailment and her family history was unremarkable as well.</p><p>Her past medical history revealed a diagnosis of pulmonary tuberculosis 20 years ago, for which she had completed a full course of standard antitubercular treatment for 6 months. Furthermore, on clinical examination, there was no hypopigmentation, loss of sensation, or thickening of peripheral nerves around the nodules. There was no evidence of localised or generalised lymphadenopathy, and the rest of the systemic examination was unremarkable.</p><p>Fine-needle aspiration cytology (FNAC) was performed on the palpable skin nodules under all aseptic precautions, yielding pus aspirate (Figure 3).</p><p>TB is one of the earliest diseases known to humanity and has been a public health concern for centuries. It is particularly prevalent in developing countries of the Indian Subcontinent [<span>1</span>]. While TB is most commonly associated with lung infections, its extrapulmonary manifestations can be quite diverse, ranging from more common cases of tubercular lymphadenitis to very rare cutaneous forms [<span>2</span>]. Diagnosing cutaneous TB through FNAC can be very challenging due to the wide range of clinical manifestations, which often present with low clinical suspicion and exhibit a diverse variety of microscopic morphologies [<span>3</span>].</p><p>A case of cutaneous TB is defined by either the identification of <i>M. tuberculosis</i> through culture, PCR (polymerase chain reaction), aspirate/biopsy of the cutaneous lesions, or by the resolution of symptoms after completing a full course of ATT. In settings with limited resources and personnel, culture, PCR, and biopsy studies may be impractical. Therefore, FNAC is a crucial part of the diagnostic process, as it can be performed easily and allows for the rapid detection of <i>M. tuberculosis</i> without requiring any invasive procedure like incisional or excisional biopsy from the lesions as evident in the present case [<span>4, 5</span>].</p><p
一个40岁的女性表现为多个慢性结节性肿胀分布在她的身体,存在于过去的一年。肿胀位于双臂、躯干、背部、左大腿和左大脚趾,起病隐匿。患者消瘦,计算体重指数(BMI)为16.17 kg/m²。结节大小不等,直径为2 ~ 5cm,出现时间不同。它们质地坚硬,触痛,伴有红斑和偶尔的擦伤。他们的溃疡程度不一,结节上可见活跃的化脓和坏死(图1和2)。她否认就诊时有咳嗽、夜热、盗汗或食欲不振史。此外,没有相关的关节痛、关节炎、神经炎、链球菌性咽炎、炎症性肠病、过敏或荨麻疹病史。此外,她没有服用任何其他疾病的慢性药物,她的家族史也很普通。她的既往病史显示20年前诊断为肺结核,为此她完成了为期6个月的标准抗结核治疗的整个疗程。此外,在临床检查中,没有色素沉着、感觉丧失或结节周围周围神经增厚。没有局部或全身性淋巴结病的证据,其余的全身检查无显著性。在所有无菌预防措施下,对可触及的皮肤结节进行细针穿刺细胞学检查(FNAC),产生脓液(图3)。结核病是人类已知最早的疾病之一,几个世纪以来一直是一个公共卫生问题。它在印度次大陆的发展中国家尤为普遍。虽然结核病最常与肺部感染相关,但其肺外表现可多种多样,从较常见的结核性淋巴结炎到非常罕见的皮肤形式[2]。由于临床表现广泛,通过FNAC诊断皮肤结核是非常具有挑战性的,这些临床表现通常表现为低临床怀疑,并表现出多种多样的显微镜形态。皮肤结核病例的定义是通过培养、PCR(聚合酶链反应)、皮肤病变抽吸/活检确定结核分枝杆菌,或在完成整个ATT疗程后症状消退。在资源和人员有限的情况下,培养、PCR和活检研究可能不切实际。因此,FNAC是诊断过程中至关重要的一部分,因为它可以很容易地进行,并且可以快速检测结核分枝杆菌,而不需要任何侵入性手术,如从病变处进行切口或切除活检,正如本病例所示[4,5]。虽然皮肤结核的发病率较低,但其范围相当广泛。弥散性或转移性结核性龈瘤是一种极为罕见的表现,仅占表现为皮肤结节的肺外结核病例的0.01%。转移性结核性牙龈肿得名于感染的传播,感染可导致不同部位的皮肤广泛受累,导致橡胶状或“胶状”肿胀[6,7]。这种情况是一种内源性获得性继发性感染,由原发性感染部位的血液传播引起。这种杆菌可以休眠数年,并可能在免疫力减弱期间重新激活;在目前的情况下,营养不良是一个促成因素。病变典型表现为坚硬的结节性皮肤肿胀,主要影响四肢和躯干,但也可发生在其他部位。这些病变的特征是化脓和发红,并且是纯皮肤的,这意味着它们不与任何邻近的感染器官相连。随着时间的推移,病变可能发展成溃疡、瘘管形成,甚至继发细菌感染。皮肤结核(TB)的诊断可能具有挑战性,因为它通常与其他皮肤病类似,如麻风病、麻风结节性红斑、利什曼病、深部真菌感染、细菌性脓肿、梅毒性牙龈和非结核性分枝杆菌感染,从而导致潜在的误诊。皮肤结核最接近的鉴别诊断是麻风病,因为这两种情况都是由抗酸分枝杆菌引起的。然而,与结核病不同,麻风病杆菌影响周围神经,导致神经增厚、虚弱、色素减退、干燥(由于汗腺受损)和敏感性降低等症状。此外,麻风杆菌的抗酸性不如结核杆菌;它们可以用5%硫酸(H2SO4)脱色,而结核杆菌需要20%硫酸脱色。 麻风杆菌较短,较粗,通常在巨噬细胞内发现,呈雪茄状束或球形排列,而结核杆菌较细,呈串珠状,通常分散在坏死碎片中。此外,切口皮肤涂片(SSS)是一项重要的诊断试验,有助于检测麻风分枝杆菌。在我们的患者中,由于缺乏麻风病的特征性临床特征和进一步确认病变[9]中结核分枝杆菌感染,因此未进行SSS。对于梅毒性牙龈,细胞学涂片显示存在带有坏死碎片的肉芽肿,但在ZN染色上未发现抗酸生物。致病细菌,梅毒螺旋体,可以可视化使用特殊的银染色[10]。FNAC是一种快速、经济、微创的方法,可提供准确的结核病诊断并排除结核病模拟物。在评估全身性坏死性皮肤结节性病变时,建议考虑印度等结核病高负担地区的结核病[11,12]。和ca负责报告和诊断病例,并对患者进行随访。A.A.和S.M.对稿件的撰写做出了主要贡献,而C.A.和S.M.则负责文章的审阅和编辑。所有的作者都阅读并批准了最终的手稿。本文中的患者已书面同意参与研究,并同意使用其未识别、匿名、汇总的数据和病例详细信息(包括照片)进行发表。伦理批准:不适用。作者声明无利益冲突。数据共享不适用——没有新数据生成,或者文章完全描述了理论研究。
{"title":"Multiple Bilateral Erythematous and Suppurative Cutaneous Nodules in a 40-Year-Old Indian Female","authors":"Aditi Anand,&nbsp;Shaivy Malik,&nbsp;Charanjeet Ahluwalia","doi":"10.1002/jvc2.70095","DOIUrl":"https://doi.org/10.1002/jvc2.70095","url":null,"abstract":"&lt;p&gt;A 40-year-old female presented with multiple chronic nodular swellings distributed across her body, present for the last 1 year. The swellings were located on both arms, trunk, back, left thigh, and the left great toe and were insidious in onset. The patient appeared emaciated, with a calculated body mass index (BMI) of 16.17 kg/m². The nodules varied in size from 2 to 5 cm in diameter and appeared at different times. They were firm in consistency, tender, and were associated with erythema and occasional excoriation. They were variably ulcerated with evidence of active suppuration and necrosis over the nodules (Figures 1 and 2). She denied any history of cough, evening fever, night sweats, or loss of appetite at the time of presentation. Furthermore, there was no history indicative of associated arthralgia, arthritis, neuritis, preceding streptococcal pharyngitis, or inflammatory bowel disease, hypersensitivity, or urticaria. Moreover, she was not on any chronic medication for any other ailment and her family history was unremarkable as well.&lt;/p&gt;&lt;p&gt;Her past medical history revealed a diagnosis of pulmonary tuberculosis 20 years ago, for which she had completed a full course of standard antitubercular treatment for 6 months. Furthermore, on clinical examination, there was no hypopigmentation, loss of sensation, or thickening of peripheral nerves around the nodules. There was no evidence of localised or generalised lymphadenopathy, and the rest of the systemic examination was unremarkable.&lt;/p&gt;&lt;p&gt;Fine-needle aspiration cytology (FNAC) was performed on the palpable skin nodules under all aseptic precautions, yielding pus aspirate (Figure 3).&lt;/p&gt;&lt;p&gt;TB is one of the earliest diseases known to humanity and has been a public health concern for centuries. It is particularly prevalent in developing countries of the Indian Subcontinent [&lt;span&gt;1&lt;/span&gt;]. While TB is most commonly associated with lung infections, its extrapulmonary manifestations can be quite diverse, ranging from more common cases of tubercular lymphadenitis to very rare cutaneous forms [&lt;span&gt;2&lt;/span&gt;]. Diagnosing cutaneous TB through FNAC can be very challenging due to the wide range of clinical manifestations, which often present with low clinical suspicion and exhibit a diverse variety of microscopic morphologies [&lt;span&gt;3&lt;/span&gt;].&lt;/p&gt;&lt;p&gt;A case of cutaneous TB is defined by either the identification of &lt;i&gt;M. tuberculosis&lt;/i&gt; through culture, PCR (polymerase chain reaction), aspirate/biopsy of the cutaneous lesions, or by the resolution of symptoms after completing a full course of ATT. In settings with limited resources and personnel, culture, PCR, and biopsy studies may be impractical. Therefore, FNAC is a crucial part of the diagnostic process, as it can be performed easily and allows for the rapid detection of &lt;i&gt;M. tuberculosis&lt;/i&gt; without requiring any invasive procedure like incisional or excisional biopsy from the lesions as evident in the present case [&lt;span&gt;4, 5&lt;/span&gt;].&lt;/p&gt;&lt;p","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"4 5","pages":"1270-1273"},"PeriodicalIF":0.5,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.70095","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145625595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urticarial Plaques With Vesicles in a Young Hispanic Woman 一名年轻西班牙女性的荨麻疹斑块伴小泡
IF 0.5 Pub Date : 2025-06-16 DOI: 10.1002/jvc2.70084
Valeria Olvera-Rodríguez, Gerardo González-Martínez, Sonia Chávez-Álvarez, Bárbara Sáenz-Ibarra, Minerva Gómez-Flores, Jorge Ocampo-Candiani, Erika Alba-Rojas
<p>A 22-year-old Hispanic woman with no prior medical history presented with a 4-month history of disseminated skin lesions. Initially, she developed pruritic papules and urticarial plaques in the perioral region, which progressively spread to the neck, chest, and upper extremities. She had been treated with intramuscular dexamethasone (8 mg) and oral loratadine (10 mg every 12 h for 2 weeks), achieving partial improvement. Physical examination revealed polycyclic and annular erythematous plaques with an urticarial appearance and scarce, small vesicles at the periphery (Figure 1). The patient denied systemic symptoms, including asthenia, arthralgia, or fever. Initial laboratory work-up showed hemoglobin 12.9 g/dL, platelets 283 × 10<sup>9</sup>/L, white blood cells 6.0 × 10<sup>9</sup>/L, and no proteinuria. Two skin biopsies were obtained for histopathologic (Figure 2) and immunohistochemical evaluation (Figure 3).</p><p>The patient was initially treated with oral prednisone (0.5 mg/kg/day), hydroxychloroquine (0.5 mg/kg/day), and topical corticosteroids. After excluding glucose-6-phosphate dehydrogenase deficiency, dapsone (50 mg daily) was initiated, resulting in significant improvement of lesions within 3 weeks. The patient met the 2019 EULAR/ACR and 2012 SLICC classification criteria for systemic lupus erythematosus (SLE). She was referred to the Rheumatology department, where no additional organ or systemic involvement was identified.</p><p>BSLE is a rare cutaneous complication of SLE, with an estimated incidence of 0.19% [<span>1, 2</span>]. Similar to SLE, BSLE predominantly affects young women, often of African descent, in their second to fourth decades of life, although it can also occur in males and other races, or age groups [<span>1, 3</span>]. Autoantibodies targeting the NC1 and NC2 domains of type VII collagen are the immunopathologic hallmark of both BSLE and epidermolysis bullosa acquisita (EBA) [<span>4</span>]. In BSLE, these autoantibodies predominantly belong to IgG2 and IgG3 subclasses, whereas in EBA, they are primarily IgG1 and IgG4 [<span>4</span>]. Additionally, bullous pemphigoid (BP) antigens (BP180 and BP230), laminin 5, and laminin 6 may also contribute to its pathogenesis [<span>5</span>].</p><p>By definition, the diagnosis of BSLE requires that patients fulfill the ACR classification criteria for SLE [<span>1, 2</span>]. BSLE typically develops in patients with established SLE but can also present as the initial manifestation in 36%–40% of cases, with onset reported up to 18 years after SLE diagnosis [<span>1, 3</span>]. Clinically, it is characterized by an acute onset of tense vesicles and bullae containing clear or hemorrhagic fluid. These lesions may arise on both inflamed and normal skin, commonly involving sun-exposed areas but occasionally appearing on nonexposed regions [<span>6</span>]. The bullae typically evolve into erosions that heal without scarring, although residual hypopigmentation or hyperpigment
22岁西班牙裔女性,无既往病史,4个月的弥散性皮肤病变史。最初,她在口腔周围出现瘙痒性丘疹和荨麻疹斑块,并逐渐扩散到颈部、胸部和上肢。患者经肌肉注射地塞米松(8mg)和口服氯雷他定(10mg / 12 h,持续2周)治疗,部分好转。体格检查显示多环状和环状红斑斑块,呈荨麻疹样,周围有少量小泡(图1)。病人否认全身症状,包括虚弱、关节痛或发烧。初步实验室检查:血红蛋白12.9 g/dL,血小板283 × 109/L,白细胞6.0 × 109/L,无蛋白尿。两例皮肤活检进行组织病理学(图2)和免疫组织化学评估(图3)。患者最初接受口服强的松(0.5 mg/kg/天)、羟氯喹(0.5 mg/kg/天)和外用皮质类固醇治疗。排除葡萄糖-6-磷酸脱氢酶缺乏症后,开始使用氨苯砜(50mg / d), 3周内病变明显改善。该患者符合2019年EULAR/ACR和2012年SLICC系统性红斑狼疮(SLE)的分类标准。她被转到风湿病科,在那里没有发现其他器官或全身受累。BSLE是SLE中一种罕见的皮肤并发症,估计发病率为0.19%[1,2]。与SLE类似,BSLE主要影响20 - 40岁的年轻女性,通常是非洲裔,尽管它也可能发生在男性和其他种族或年龄组[1,3]。针对VII型胶原NC1和NC2结构域的自身抗体是BSLE和获得性大疱性表皮松解症(EBA)[4]的免疫病理学标志。在BSLE中,这些自身抗体主要属于IgG2和IgG3亚类,而在EBA中,它们主要是IgG1和IgG4[4]。此外,大疱性类天疱疮(BP)抗原(BP180和BP230)、层粘连蛋白5和层粘连蛋白6也可能参与其发病机制[5]。根据定义,BSLE的诊断需要患者满足SLE的ACR分类标准[1,2]。BSLE通常发生在已确诊的SLE患者中,但也可能在36%-40%的病例中以初始表现出现,据报道发病时间长达SLE诊断后18年[1,3]。临床上,它的特点是急性发作紧张的囊泡和大泡含有透明或出血性液体。这些病变可能出现在发炎和正常皮肤上,通常涉及暴露在阳光下的区域,但偶尔也会出现在未暴露的区域。大疱通常演变成糜烂,愈合后无瘢痕,尽管经常观察到残留的色素沉着或色素沉着。瘙痒一般是轻微的,尽管有些病人报告有烧灼感。BSLE很少是孤立的,通常与SLE的皮外表现共存。在de Risi等人最近的一项研究中,在大多数患者中观察到中度至重度疾病活动。在50%的病例中观察到狼疮肾炎,表明BSLE可能作为严重疾病的标志。然而,已有研究表明,抗VII型胶原抗体水平与疾病活动性[3]相关性最强。分别有50%和20%的患者出现关节痛或关节炎和神经系统受累。有趣的是,在这个病例中,BSLE是SLE的初始特征,在1年的随访中没有发现系统性的累及。BSLE的组织病理学类似疱疹样皮炎(DH),表现为表皮下起泡、真皮水肿、真皮上部富含中性粒细胞浸润,在真皮乳头[2]内形成微脓肿。网状真皮中的粘蛋白沉积是BSLE[6]的显著特征。其他类型CLE的经典特征一般不存在。DIF研究显示DEJ处有IgG、IgM、IgA和C3的线性或粒状沉积[2,3]。在大约一半的病例中,可以通过间接免疫荧光(IIF)和盐裂皮肤IIF检测到靶向基膜区的自身抗体,主要与真皮侧结合[1,3]。最近,一种酶联免疫分析法被用于检测VII型胶原[5]的NC1和NC2自身抗体。BSLE的诊断标准由Camisa[7]于1983年首次提出,并于1988年进行了修订,纳入了临床、组织病理学和免疫病理学特征。最终,BSLE与其他原发性大疱性皮肤病有相似之处,尤其是BP、DH和EBA[2,4,8]。重叠的模式突出了诊断的复杂性。使用临床正常皮肤样本的LBT已被提议作为一种有用的SLE诊断试验。非病变性LBT显示高特异性(88.2% - 98%)。 8%),支持其在确认SLE中的效用,但其低敏感性(17.6%-56.5%)限制了其在排除疾病方面的价值[9,10]。氨苯砜是轻度BSLE的一线治疗药物,疗效高达90%,几天内快速反应。典型剂量从每天50毫克开始,逐渐增加到每天150-200毫克,但23%的病例会出现副作用[3,6]。对于不耐受、禁忌症或系统性SLE表现的病例,建议使用免疫抑制剂,如环磷酰胺、霉酚酸酯、甲氨蝶呤或硫唑嘌呤[1,3,6]。利妥昔单抗对难治性BSLE[11]有疗效。本病例强调了将BSLE视为LES的一种罕见表现的重要性,特别是在未被充分代表的人口统计学中,如西班牙裔女性b[3]。提高不同皮肤表型的诊断准确性对于确保所有人群的及时诊断和适当治疗仍然至关重要。瓦莱里娅Olvera-Rodríguez:概念化,获取数据,撰写原始草案准备。Gerardo González-Martínez:概念化,数据获取。索尼娅Chávez-Álvarez:调查,监督。Bárbara Sáenz-Ibarra:解释皮肤的组织病理学和直接免疫荧光研究。Minerva Gómez-Flores:监督。Jorge Ocampo-Candiani:监督。Erika Alba-Rojas:概念化,监督,最终稿件批准。本文中的所有患者均已书面同意参与本研究,并同意使用其去识别、匿名、汇总的数据和病例详细信息(包括照片)进行发表。伦理批准:不适用。作者声明无利益冲突。
{"title":"Urticarial Plaques With Vesicles in a Young Hispanic Woman","authors":"Valeria Olvera-Rodríguez,&nbsp;Gerardo González-Martínez,&nbsp;Sonia Chávez-Álvarez,&nbsp;Bárbara Sáenz-Ibarra,&nbsp;Minerva Gómez-Flores,&nbsp;Jorge Ocampo-Candiani,&nbsp;Erika Alba-Rojas","doi":"10.1002/jvc2.70084","DOIUrl":"https://doi.org/10.1002/jvc2.70084","url":null,"abstract":"&lt;p&gt;A 22-year-old Hispanic woman with no prior medical history presented with a 4-month history of disseminated skin lesions. Initially, she developed pruritic papules and urticarial plaques in the perioral region, which progressively spread to the neck, chest, and upper extremities. She had been treated with intramuscular dexamethasone (8 mg) and oral loratadine (10 mg every 12 h for 2 weeks), achieving partial improvement. Physical examination revealed polycyclic and annular erythematous plaques with an urticarial appearance and scarce, small vesicles at the periphery (Figure 1). The patient denied systemic symptoms, including asthenia, arthralgia, or fever. Initial laboratory work-up showed hemoglobin 12.9 g/dL, platelets 283 × 10&lt;sup&gt;9&lt;/sup&gt;/L, white blood cells 6.0 × 10&lt;sup&gt;9&lt;/sup&gt;/L, and no proteinuria. Two skin biopsies were obtained for histopathologic (Figure 2) and immunohistochemical evaluation (Figure 3).&lt;/p&gt;&lt;p&gt;The patient was initially treated with oral prednisone (0.5 mg/kg/day), hydroxychloroquine (0.5 mg/kg/day), and topical corticosteroids. After excluding glucose-6-phosphate dehydrogenase deficiency, dapsone (50 mg daily) was initiated, resulting in significant improvement of lesions within 3 weeks. The patient met the 2019 EULAR/ACR and 2012 SLICC classification criteria for systemic lupus erythematosus (SLE). She was referred to the Rheumatology department, where no additional organ or systemic involvement was identified.&lt;/p&gt;&lt;p&gt;BSLE is a rare cutaneous complication of SLE, with an estimated incidence of 0.19% [&lt;span&gt;1, 2&lt;/span&gt;]. Similar to SLE, BSLE predominantly affects young women, often of African descent, in their second to fourth decades of life, although it can also occur in males and other races, or age groups [&lt;span&gt;1, 3&lt;/span&gt;]. Autoantibodies targeting the NC1 and NC2 domains of type VII collagen are the immunopathologic hallmark of both BSLE and epidermolysis bullosa acquisita (EBA) [&lt;span&gt;4&lt;/span&gt;]. In BSLE, these autoantibodies predominantly belong to IgG2 and IgG3 subclasses, whereas in EBA, they are primarily IgG1 and IgG4 [&lt;span&gt;4&lt;/span&gt;]. Additionally, bullous pemphigoid (BP) antigens (BP180 and BP230), laminin 5, and laminin 6 may also contribute to its pathogenesis [&lt;span&gt;5&lt;/span&gt;].&lt;/p&gt;&lt;p&gt;By definition, the diagnosis of BSLE requires that patients fulfill the ACR classification criteria for SLE [&lt;span&gt;1, 2&lt;/span&gt;]. BSLE typically develops in patients with established SLE but can also present as the initial manifestation in 36%–40% of cases, with onset reported up to 18 years after SLE diagnosis [&lt;span&gt;1, 3&lt;/span&gt;]. Clinically, it is characterized by an acute onset of tense vesicles and bullae containing clear or hemorrhagic fluid. These lesions may arise on both inflamed and normal skin, commonly involving sun-exposed areas but occasionally appearing on nonexposed regions [&lt;span&gt;6&lt;/span&gt;]. The bullae typically evolve into erosions that heal without scarring, although residual hypopigmentation or hyperpigment","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"4 4","pages":"946-949"},"PeriodicalIF":0.5,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.70084","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144923543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JEADV clinical practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1